Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immunome Inc (IMNM)

Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 582,351
  • Shares Outstanding, K 62,417
  • Annual Sales, $ 14,020 K
  • Annual Income, $ -106,810 K
  • EBIT $ -237 M
  • EBITDA $ -236 M
  • 60-Month Beta 1.82
  • Price/Sales 41.81
  • Price/Cash Flow N/A
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 133.68% ( +68.95%)
  • Historical Volatility 63.55%
  • IV Percentile 98%
  • IV Rank 83.00%
  • IV High 154.41% on 11/18/24
  • IV Low 32.44% on 09/03/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 68
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,604
  • Open Int (30-Day) 1,605

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.72
  • Number of Estimates 5
  • High Estimate -0.60
  • Low Estimate -0.81
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.97 +4.24%
on 11/20/24
13.66 -31.55%
on 11/06/24
-2.56 (-21.49%)
since 10/21/24
3-Month
8.97 +4.24%
on 11/20/24
16.73 -44.11%
on 09/16/24
-5.85 (-38.49%)
since 08/21/24
52-Week
6.93 +34.92%
on 12/14/23
30.96 -69.80%
on 03/07/24
+1.40 (+17.61%)
since 11/21/23

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, KLR, IMNM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
KLR : 7.24 (-0.14%)
IMNM : 9.47 (+1.50%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMNM, CPRI, AVID

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMNM : 9.47 (+1.50%)
CPRI : 19.79 (-1.25%)
AVID : 27.04 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
AJX : 2.95 (unch)
IMNM : 9.47 (+1.50%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
WMC : 9.18 (+4.44%)
IMNM : 9.47 (+1.50%)
AJX : 2.95 (unch)
IMPORTANT ALERT: Halper Sadeh LLC Investigates DICE, IMNM, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DICE : 47.55 (+0.06%)
IMNM : 9.47 (+1.50%)
AJX : 2.95 (unch)
Shareholder Alert: Ademi LLP investigates whether Immunome, Inc. has obtained a Fair Price in its Private Placement and its transaction with Morphimmune

/PRNewswire/ -- Ademi LLP is investigating Immunome (Nasdaq: IMNM) for possible breaches of fiduciary duty and other violations of law in its private placement...

IMNM : 9.47 (+1.50%)
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies

Immunome (Nasdaq: IMNM), a biopharmaceutical company specializing in antibody therapeutics, and Morphimmune, a biotech firm known for targeted oncology therapeutics, have entered into a definitive merger...

PFE : 24.84 (-0.40%)
IMNM : 9.47 (+1.50%)
Immunome Reports First Quarter 2023 Financial Results

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported...

IMNM : 9.47 (+1.50%)
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported...

IMNM : 9.47 (+1.50%)
Immunome to Present at 13th Annual World ADC London Conference

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop antibody therapeutics to improve patient care, today announced that Matthew...

IMNM : 9.47 (+1.50%)

Business Summary

Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.

See More

Key Turning Points

3rd Resistance Point 9.86
2nd Resistance Point 9.61
1st Resistance Point 9.47
Last Price 9.47
1st Support Level 9.08
2nd Support Level 8.83
3rd Support Level 8.69

See More

52-Week High 30.96
Fibonacci 61.8% 21.78
Fibonacci 50% 18.94
Fibonacci 38.2% 16.11
Last Price 9.47
52-Week Low 6.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar